Weekly news updates are currently posted on the Internet site and sent out via e-blast to provide up-to-date information on what has been covered in the news regarding lung cancer in the previous week. Topics include all stories related to lung cancer as well as personal stories and events.
Week ending March 1, 2015
“A group of lung cancer survivors was chatting online last May about what they thought was a big problem: Influential treatment guidelines published by a consortium of prominent cancer centers didn’t reflect an option that several people thought had saved their lives. They wanted to change that.”
OMAHA, Neb. —“Lung cancer is the leading cause of cancer death in both men and women, according to American Cancer Society.”
“A collaborative work between researchers from the Medical College of Wisconsin (MCW) and the Genetic Epidemiology of Lung Cancer Consortium (GELCC) identified a gene that links early-onset Parkinson’s disease and familial lung cancer. The study entitled “A Recurrent Mutation in PARK2 Is Associated with Familial Lung Cancer” was published in American Journal of Human Genetics.”
(CNN) — “More people may die from undiagnosed lung cancer because they don’t qualify for low-dose CT scans, according to a study by Mayo Clinic researchers. The researchers blame current screening guidelines that have remained the same despite the decline in smoking rates in the U.S.”
“A recent study found that specific factors impact family involvement in decisions regarding cancer patients’ treatment. The research, published in the Cancer journal, provides some insights that may help physicians understand patients’ preferences regarding their care.”
“The FDA has accepted Bristol-Myers Squibb’s ($BMY) application to get its star oncology treatment approved for lung cancer, setting up a speedy approval and putting the company first in line among drug developers at work in a blockbuster field.”